All In MedTech

FDA Clearance Tracker · P160044

ABBOTT REALTIME CMV

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 19, 2026Latest source record: May 18, 2017 (this decision)Source: openFDAMethods & limitations

PMA

Decided

May 18, 2017

Approved (reclassified)

Time to decision

226 days

Received Oct 4, 2016. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA

Device class

Class II

The decision

FDA number
P160044
Device name
ABBOTT REALTIME CMV
Applicant location
Des Plaines, IL
Received
Oct 4, 2016
Decided
May 18, 2017
Decision
Approved (reclassified)
Supplements
5 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class II
Regulation
21 CFR 866.3180

Every decision under product code PAB

FDA's approval statement

As written in FDA's record.

Approval for the Abbott RealTime CMV test is an in vitro polymerase chain reaction (PCR) assay for the quantitation of cytomegalovirus (CMV) DNA in human EDTA plasma. The Abbott RealTime CMV test is intended for use as an aid in the management of Hematopoietic Stem Cell Transplant patients who are undergoing anti-cytomegalovirus therapy. In this population, serial DNA measurement can be used to assess virological response to anti-cytomegalovirus therapy. The results from the RealTime CMV test must be interpreted within the context of all relevant clinical and laboratory findings. The RealTime CMV test is not intended as a screening test for the presence of CMV DNA in blood or blood products.

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code PAB. The earliest in FDA's data is P110037, decided Jul 5, 2012.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Abbott Molecular

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.